Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with two hallmarks: β‐
amyloid plagues and neurofibrillary tangles. It is one of the most alarming illnesses to elderly …

In recent years the amyloid cascade hypothesis of Alzheimer disease (AD) has been
increasingly referred to as the amyloid β protein (Aβ) cascade hypothesis. This subtle …

Most current Alzheimer's disease (AD) therapies in advanced phases of development target
amyloid β-peptide (Aβ) production, aggregation, or accumulation. Translational models …

Alzheimer's disease (AD) is a central nervous system disease characterized by progressive
cognitive dysfunction and memory loss. Increasing evidences suggest that β amyloid (Aβ) …

Alzheimer's disease is an age-related neurodegenerative disorder that results in
progressive cognitive impairment and death. The accumulation of β-amyloid (Aβ) in specific …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …

Brain accumulation of the amyloid-β (Aβ) peptide is believed to be the initial event in the
Alzheimer disease (AD) process. Aβ accumulation begins 15–20 years before clinical …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder related to age,
characterized by the cerebral deposition of fibrils, which are made from the amyloid-β (Aβ), a …

The amyloid cascade hypothesis has always been a research focus in the therapeutic field
of Alzheimer's disease (AD) since it was put forward. Numerous researchers attempted to …